Research explained
Tinnitus science is moving from subjective to measurable: what a blood biomarker would change
UConn studies link a blood protein, prestin, to chronic tinnitus. It is not a test yet. Here is what it could change, and what to do now.
Read time: 4 min read
Millions of people live with ringing that no one else can hear. Today, we cannot measure it with a test. You describe it, and we believe you. Researchers now see a possible way to measure it. That could one day make tinnitus easier to explain to family and doctors. It could also help match people to the right treatment. For you, the lesson is simple: good care already exists, and it does not depend on this research.
Below, we explain the research in plain language: what the team did, what it found, and what it does not show. This page is accurate as of October 12, 2026.
“Today we measure tinnitus by asking you about it. A blood marker would add a second kind of evidence. It would not replace the conversation or the hearing test.”
Why this research matters
Today, tinnitus is measured by asking you about it. You tell us how loud it is, how often it shows up, and how much it disturbs your sleep, focus and mood. We use validated questionnaires to put numbers on those answers. The method works well. But it rests on self-report, and that has limits. Two people can describe the same sound very differently. Researchers cannot easily compare groups, and trials struggle to show whether a treatment changed the underlying problem or only the way a person felt that week. A blood marker, if one proves reliable, could add a second kind of evidence. That is why the prestin papers drew attention.
What the researchers found
Prestin is a motor protein in the outer hair cells of the cochlea, the inner ear's hearing organ. These cells change length in response to sound. That motion boosts faint sounds. Prestin drives it. The UConn team, led by Dr. Kourosh Parham, asked a simple question: if those cells are stressed, could prestin leak into the blood? They ran two clinical studies. Study 1 compared 49 adults with chronic tinnitus and 40 controls. It used a Western blot method and pointed to a 97 kDa form of prestin as the candidate. (Otology & Neurotology 2026;47(3):e500–e507.). Study 2 compared 41 adults with bilateral tinnitus and 41 controls. The team tested four inner-ear proteins: prestin, otoferlin, connexin 26 and stereocilin. Only prestin separated the two groups. The tinnitus group averaged about 330 pg/mL more. The gap held after the team adjusted for age, hearing thresholds and noise exposure. Participants wore noise dosimeters for a week to measure the last factor. (Otolaryngology–Head and Neck Surgery, July 2026.). Dr. Parham describes the work as proof of concept. He holds a patent on a prestin blood test, which is worth knowing when you read his summaries of the results.
What the studies do and do not show
Larger studies in other labs must repeat the work before anyone can build a clinical test on it.
| Question | What the studies show | What they do not show |
|---|---|---|
| Is prestin higher in tinnitus? | Yes, on average, in two small groups | That it is higher in every person with tinnitus |
| Does it follow severity? | Prestin did not track symptom severity | That a high level means worse tinnitus |
| Where does the prestin come from? | Prestin is made in outer hair cells | That the blood prestin came from the ear. Prestin also appears in other tissue, such as the heart |
| Does it prove a cochlear cause? | Findings fit a peripheral (ear) contribution | That tinnitus starts in the cochlea. Central brain mechanisms are not ruled out |
| Is it a diagnostic test? | It separated groups on average | Accuracy high enough to diagnose one person |
| Who took part? | Mostly people with mild tinnitus | Results in severe or recent-onset tinnitus |
What a biomarker could add, and what it would not replace
If prestin or a similar marker holds up, it could help in three ways. It could give trials an objective endpoint. It could help sort tinnitus into subtypes, which would help match people to treatments. It could also steer drug development toward a defined target. It would not replace the evaluation. A number in the blood cannot tell us what your tinnitus sounds like, what makes it spike, how it affects your sleep, or what your ears and hearing look like. Those questions drive treatment choices now, and they will keep doing so.
What a tinnitus evaluation covers today
A tinnitus evaluation at our Westchester offices usually includes these parts: Your story. When it started, which ear, what it sounds like, what changes it, and what else is going on with your health. A full hearing evaluation. Most people with tinnitus have some hearing change, even when they feel they hear well. See what happens during a comprehensive hearing evaluation. Standard questionnaires that measure how much tinnitus affects daily life. A plan built on your results. That may include counseling, sound therapy, hearing aids, or a neuromodulation option. Where the history points to a medical cause, we refer you to a physician. Read more about our approach on the tinnitus management and tinnitus therapy pages. New trial data on sound therapy through hearing aids is covered in our companion article: sound therapy through hearing aids and tinnitus.
How this connects to Lenire candidacy
Lenire is a bimodal neuromodulation device. It pairs sound with mild tongue stimulation. The FDA authorized it through the De Novo pathway in March 2023, and its main trial (TENT-A3, Nature Communications 2024, 112 participants) came from the manufacturer's research program, so we read those claims with care. We decide candidacy after an evaluation, not before it. Hearing profile, tinnitus history, other treatments tried, and practical factors all count. Our Lenire candidate guide explains how we think about this. A future biomarker might help match people to devices. Today, the evaluation does that job.
What this means for you
If your tinnitus bothers you now, you do not wait for a blood test. Book an evaluation. If your tinnitus started suddenly, affects one ear only, pulses with your heartbeat, or comes with dizziness or weakness, seek medical care promptly instead. Book a tinnitus evaluation in Harrison or Somers.
Status and last update
Last updated October 12, 2026. Change note: this is the first version. We will update this page if the final paper, replication studies or clinical guidance change the picture. Sources are listed at the end of this page.
Medical information notice
This article explains published research for general education. It is not medical advice, and it does not diagnose or treat any condition. Talk with a licensed professional about your own situation.
Common questions
Is there a blood test for tinnitus?
No. Prestin is a research finding. No validated blood test for tinnitus is available to patients, and we do not offer prestin testing. Researchers need larger studies before a test could reach clinics.
What is prestin?
Prestin is a protein in the outer hair cells of the inner ear. It lets those cells change length, which boosts quiet sounds. Researchers think it may enter the blood when these cells are stressed, but that idea still needs more proof.
Does a high prestin level mean my tinnitus started in my ear?
Not necessarily. Prestin also occurs outside the ear, and the studies could not separate ear causes from brain-based ones. Tinnitus often involves both.
Will a blood test replace the hearing and tinnitus evaluation?
Unlikely. A blood marker would add one piece of evidence. Your history, hearing results and daily impact would still guide care.
Can tinnitus be cured?
Most chronic tinnitus cannot be cured today. Many people reduce how much it bothers them with counseling, sound therapy, hearing care and other tools. We aim for relief you can feel, not a promise of silence.
Should I do anything differently because of this news?
Only if your tinnitus bothers you. In that case, book an evaluation now. The research does not change what good care looks like this year.
Get one email if larger prestin studies appear.
We will write once if larger prestin studies appear or a validated tinnitus test becomes available. We will send nothing else.
Sources and further reading
- UConn Today: UConn study strongly links blood prestin with tinnitus
- MedicalXpress: elevated ear protein in blood linked to tinnitus (Oct 6, 2026)
- New Atlas: protein may detect and treat tinnitus
- JAMA Neurology 2022: global prevalence and incidence of tinnitus (doi:10.1001/jamaneurol.2022.0427)
- American Academy of Otolaryngology–Head and Neck Surgery Foundation: clinical practice guidelines, including the 2014 tinnitus guideline
